Clinical trial
Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of…
NCT00057369 · Vicuron Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00057369 |
|---|---|
| Title | Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections |
| Official title | Phase II, Randomized, Open-Label, Multi-Center Study to Evaluate the Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections With Suspected or Confirmed Gram-Positive Bacterial Pathogens |
| Lead sponsor | Vicuron Pharmaceuticals, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bacteremia |
| Intervention type | Drug |
| Interventions | dalbavancin |
| Enrollment | 88 |
| Start date | Feb 1, 2001 |
| Completion | Jun 1, 2003 |
| First posted | Apr 2, 2003 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: